Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors.
Phuangsawai O, Beswick P, Ratanabunyong S, Tabtimmai L, Suphakun P, Obounchoey P, Srisook P, Horata N, Chuckowree I, Hannongbua S, Ward SE, Choowongkomon K, Gleeson MP.
Phuangsawai O, et al. Among authors: suphakun p.
Eur J Med Chem. 2016 Nov 29;124:896-905. doi: 10.1016/j.ejmech.2016.08.055. Epub 2016 Aug 30.
Eur J Med Chem. 2016.
PMID: 27668758